Mehmet Cilingiroglu
Overview
Explore the profile of Mehmet Cilingiroglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
191
Citations
858
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Desai S, Aziz M, Marmagkiolis K, Cilingiroglu M, Iliescu C, Ynalvez L
Curr Cardiol Rep
. 2025 Mar;
27(1):65.
PMID: 40035980
Purpose Of Review: This review examines the current evidence and management strategies for stable coronary artery disease (CAD) and acute coronary syndrome (ACS) in patients with cancer. We outline the...
2.
Soleimani H, Mohammadi N, Montazeri Namin S, Nasrollahizadeh A, Azardar T, Najafi K, et al.
Curr Hypertens Rev
. 2025 Feb;
PMID: 39950476
Background: According to current clinical practice guidelines, ambulatory blood pressure measurement (ABPM) is recommended to confirm diagnoses of hypertension. It remains unclear as to which method is superior in predicting...
3.
Marmagkiolis K, Caballero J, Votsis S, Ninios V, Cilingiroglu M, Boudoulas K, et al.
Catheter Cardiovasc Interv
. 2025 Feb;
PMID: 39910697
In 2023-2024, there was a surge in research on structural heart disease. This review aims to provide a comprehensive overview of the field for both general and interventional cardiologists, especially...
4.
Mutlu D, Akman Z, Belpinar M, Iliescu C, Marmagkiolis K, Cilingiroglu M
J Invasive Cardiol
. 2025 Jan;
PMID: 39745724
No abstract available.
5.
Mutlu D, Inanc I, Zanbak Mutlu O, Marmagkiolis K, Iliescu C, Cilingiroglu M
US Cardiol
. 2024 Nov;
18:e20.
PMID: 39588174
The absence of a Food and Drug Administration-approved percutaneous valve technology for the treatment of severe aortic regurgitation (AR) presents a challenge for high-risk patients. In this report, we describe...
6.
Cilingiroglu M, Inanc I
Catheter Cardiovasc Interv
. 2024 Sep;
104(7):1548-1549.
PMID: 39342489
No abstract available.
7.
Marmagkiolis K, Monlezun D, Caballero J, Cilingiroglu M, Brown M, Ninios V, et al.
Int J Cardiol
. 2024 Apr;
408:132091.
PMID: 38663811
Introduction: We conducted the first comprehensive evaluation of the therapeutic value and safety profile of transcatheter mitral edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR) in individuals concurrently afflicted...
8.
Inanc I, Mutlu D, Marmagkiolis K, Iliescu C, Ates I, Cilingiroglu M
Cardiovasc Revasc Med
. 2024 Feb;
64:21-24.
PMID: 38388247
Background: With the advances in percutaneous treatment technologies, the left atrial appendage occlusion (LAAO) and the transcatheter mitral valve repair using MitraClip (TMVR) are increasingly being performed today. The SAFARI...
9.
Gruslova A, Inanc I, Cilingiroglu M, Katta N, Milner T, Feldman M
Catheter Cardiovasc Interv
. 2023 Dec;
103(2):295-307.
PMID: 38091341
Management of intracoronary calcium (ICC) continues to be a challenge for interventional cardiologists. There have been significant advances in calcium treatment devices. However, there still exists a knowledge gap regarding...
10.
Gruslova A, Katta N, Nolen D, Jenney S, Vela D, Buja M, et al.
EuroIntervention
. 2023 Dec;
19(11):e913-e922.
PMID: 38060282
Background: Electrical intravascular lithotripsy (E-IVL) uses shock waves to fracture calcified plaque. Aims: We aimed to demonstrate the ability of laser IVL (L-IVL) to fracture calcified plaques in ex vivo...